Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3004 articles
Articles
Global Glucose Gummies Market Projected to Reach USD 848.4 Million by 2036, Driven by Metabolic Wellness Trends and E-Commerce Expansion
The glucose gummies market is poised for significant growth, with projections indicating a rise to USD 848.4 million by 2036, fueled by increasing consumer demand for convenient, chewable metabolic wellness supplements and the expansion of digital retail channels.
July 2, 2026Read the full article
Quantum BioPharma Highlights MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman Anthony Durkacz discussed the company's lead multiple sclerosis drug candidate Lucid-MS and its alcohol metabolism accelerator unbuzzd on the BioMedWire Podcast, emphasizing the importance of executive thought leadership in biotech communications.
July 1, 2026Read the full article
Cardio Diagnostics Showcases Precision Cardiovascular Solutions for Employers and Health Plans
Cardio Diagnostics Holdings (CDIO) presented its AI-driven cardiovascular risk assessment tools at national benefits conferences, emphasizing how early detection can improve health outcomes and reduce healthcare costs for employers and health plans.
July 1, 2026Read the full article
HeartBeam Advances Cardiac Monitoring Beyond Hospital Walls with Portable 12-Lead ECG System
HeartBeam's FDA-cleared, cable-free ECG system enables synthesis of a 12-lead ECG outside clinical settings, potentially improving early intervention and personalized cardiac care.
July 1, 2026Read the full article
Extreme Heat Puts Heart Health at Greater Risk, American Heart Association Warns
As temperatures rise, the American Heart Association warns that extreme heat can strain the heart and increase the risk of cardiovascular complications, potentially leading to more than double the heat-related cardiovascular deaths in the coming decades.
July 1, 2026Read the full article
American Heart Association Announces Volunteer Leaders for 2026-27
The American Heart Association has appointed Dr. Manesh R. Patel as volunteer president and Lee A. Shapiro as continuing chairperson of the board, bringing expertise in cardiology, health technology, and business governance to guide the organization's mission.
July 1, 2026Read the full article
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer as It Advances Phase 3 Alzheimer's Study
Annovis Bio announced the promotion of Dr. Cheng Fang to Chief Scientific Officer, positioning the company to lead scientific strategy through upcoming clinical milestones including top-line data from its pivotal Phase 3 Alzheimer's study.
July 1, 2026Read the full article
GLP-1 Medications May Reduce Deaths, Amputations in Type 2 Diabetes Patients with PAD
A new study finds that GLP-1 receptor agonists significantly reduce deaths, amputations, and hospitalizations in people with Type 2 diabetes and peripheral artery disease, especially those with severe blockages or obesity.
July 1, 2026Read the full article
Active Hybrid Humidification Incubator Market Projected to Reach USD 229.2 Million by 2036, Driven by Demand for Advanced Cell Culture Systems
The global active hybrid humidification incubator market is expected to grow from USD 90.0 million in 2026 to USD 229.2 million by 2036, fueled by increasing need for precision-controlled environments in cell culture and biotech applications.
July 1, 2026Read the full article
Nashville Concierge Medicines Releases New Educational Content on GLP-1 Treatment for Diabetes Management
Nashville Concierge Medicines announces new content on GLP-1 semaglutide treatment, emphasizing the importance of personalized, holistic care for diabetes management in a private doctor setting.
July 1, 2026Read the full article
Next-Generation Precision Obesity Models: Closing the Translational Gap in Anti-Obesity Drug Development
As GLP-1 drugs surge in popularity, the complexity of next-generation anti-obesity therapeutics demands more predictive preclinical models to improve clinical translation success rates.
July 1, 2026Read the full article
Disposable Endoscope Valves Market Forecast to Reach $1.1 Billion by 2036 as Infection Prevention Standards Accelerate Shift Toward Single-Use Endoscopy Accessories
The global disposable endoscope valves market is projected to grow from $0.6 billion in 2026 to $1.1 billion by 2036, driven by rising endoscopy procedures, stricter infection prevention standards, and increasing adoption of sterile single-use accessories.
July 1, 2026Read the full article
Odor Scavenger Packaging Additives Market Set to Reach USD 1,754.4 Million by 2036 as Recycled Plastics Adoption, Food Safety Requirements, and Active Packaging Innovation Accelerate Global Growth
The global odor scavenger packaging additives market is projected to grow from USD 640.6 million in 2026 to USD 1,754.4 million by 2036, driven by recycled plastic adoption, food safety needs, and active packaging innovation.
July 1, 2026Read the full article
Pulmonary Mesh Nebulizers Market Set to Reach $3.8 Billion by 2036 as Home Respiratory Care and Portable Aerosol Therapy Transform Treatment Delivery
The pulmonary mesh nebulizers market is projected to grow from $1.2 billion in 2026 to $3.8 billion by 2036, driven by rising chronic respiratory diseases and a shift toward home-based care.
July 1, 2026Read the full article
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam finished patient enrollment early in its ALIGN-ACS pilot study for heart attack detection, with results expected to support FDA discussions and potential accelerated regulatory approval.
June 30, 2026Read the full article
Cardio Diagnostics Highlights Precision Cardiovascular Solutions for Employers and Health Plans at National Benefits Conferences
Cardio Diagnostics Holdings showcases how its AI-driven precision cardiovascular tools can help employers and health plans reduce costs and improve outcomes through early risk detection and preventive care.
June 30, 2026Read the full article
Cardio Diagnostics Holdings Uses Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings (CDIO) leverages epigenetics to reveal hidden heart disease risks beyond genetics, offering insights into how lifestyle and environment influence gene expression.
June 30, 2026Read the full article
Cardio Diagnostics Showcases Precision Cardiovascular Tools for Employers and Health Plans at National Benefits Conferences
Cardio Diagnostics Holdings (NASDAQ: CDIO) presented its AI-driven precision cardiovascular solutions at multiple national benefits conferences, emphasizing how earlier detection and risk assessment can improve health outcomes and reduce healthcare costs for employers and health plans.
June 30, 2026Read the full article
Klarify Launches AI Operating System for Therapists to Combat Administrative Overload and Insurance Challenges
Klarify, backed by Y Combinator, has launched an AI-powered operating system for therapists to handle administrative tasks like documentation and insurance workflows, aiming to address burnout and an AI imbalance with insurers.
June 30, 2026Read the full article
SS Innovations International Wins 2026 Surgical Robotics Industry Outstanding Company Award
SS Innovations International (NASDAQ: SSII) has been awarded the Outstanding Company award at the 2026 Surgical Robotics Industry Awards, highlighting the growing adoption of its SSi Mantra surgical robotic system with over 11,700 procedures performed across 14 countries.
June 30, 2026Read the full article
FDA-Approved Drug May Enhance Immunotherapy for Rare Liver Cancer
Researchers at the University of Washington discovered that an FDA-approved drug could boost immunotherapy efficacy against fibrolamellar carcinoma, a rare liver cancer previously unresponsive to checkpoint inhibitors.
June 30, 2026Read the full article